Gallagher Fiduciary Advisors’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$593K Sell
30,415
-1,044
-3% -$20.7K 0.02% 164
2026
Q1
$605K Sell
31,459
-3,403
-10% -$67K 0.02% 132
2025
Q4
$660K Buy
34,862
+2,557
+8% +$47.4K 0.02% 146
2025
Q3
$602K Buy
32,305
+647
+2% +$12.1K 0.02% 129
2025
Q2
$584K Buy
31,658
+5,756
+22% +$102K 0.02% 153
2025
Q1
$453K Buy
25,902
+1,527
+6% +$25.7K 0.01% 170
2024
Q4
$422K Buy
24,375
+3,898
+19% +$71.2K 0.08% 167
2024
Q3
$381K Buy
20,477
+4,981
+32% +$84K 0.08% 159
2024
Q2
$239K Buy
+15,496
New +$221K 0.05% 203

Other funds holding SBRA

Gallagher Fiduciary Advisors's SBRA Position: Q2 2026 in Review

Gallagher Fiduciary Advisors reduced its Sabra Healthcare REIT (SBRA) stake by 3.3% in Q2 2026, selling an estimated $20.7K and leaving 30,415 shares worth $593K. The position accounts for 0.02% of the portfolio, ranked #164.

Gallagher Fiduciary Advisors first reported a position in SBRA in Q2 2024 and has held it in 9 quarters since. The position peaked at $660K in Q4 2025. 465 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Gallagher Fiduciary Advisors held 30,415 shares of Sabra Healthcare REIT worth $593K as of Q2 2026.
  • Gallagher Fiduciary Advisors sold 1,044 Sabra Healthcare REIT shares in Q2 2026, an estimated $20.7K.
  • Sabra Healthcare REIT made up 0.02% of Gallagher Fiduciary Advisors's portfolio in Q2 2026, its #164 holding.
  • Gallagher Fiduciary Advisors first reported a position in Sabra Healthcare REIT in Q2 2024 and has held it in 9 quarters since.
  • Gallagher Fiduciary Advisors's Sabra Healthcare REIT position peaked at $660K in Q4 2025.
  • 465 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Gallagher Fiduciary Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.